Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
- DOI
- 10.1007/s00280-010-1424-8
- Published
- 2011 Jul
- Container
- Cancer chemotherapy and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-010-1424-8,
title = {Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.},
author = {Cascinu S and Galizia E and Labianca R and Ferraù F and Pucci F and Silva RR and Luppi G and Beretta GD and Berardi R and Scartozzi M},
year = {2011},
journal = {Cancer chemotherapy and pharmacology},
doi = {10.1007/s00280-010-1424-8},
url = {https://doi.org/10.1007/s00280-010-1424-8}
}RIS
TY - JOUR TI - Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial. AU - Cascinu S AU - Galizia E AU - Labianca R AU - Ferraù F AU - Pucci F AU - Silva RR AU - Luppi G AU - Beretta GD AU - Berardi R AU - Scartozzi M PY - 2011 JO - Cancer chemotherapy and pharmacology DO - 10.1007/s00280-010-1424-8 UR - https://doi.org/10.1007/s00280-010-1424-8 ER -
APA
S, C., E, G., R, L., F, F., F, P., RR, S., G, L., GD, B., R, B., & M, S. (2011). Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-010-1424-8
Source records
- pubmed · retrieved 2026-09-27T15:56:22.616Z